Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ACTRN12626000916347) titled 'Hydrogen-rich water supplementation for adults with metabolic syndrome' on July 24.

Study Type: Interventional

Study Design: Purpose: Treatment Allocation: Randomised controlled trial Masking: Blinded (masking used) Assignment: Parallel

Primary Sponsor: Southern Cross University

Condition: metabolic syndrome metabolic syndrome Metabolic and Endocrine - Metabolic disorders

Intervention: Hydrogen-rich water, generated by dissolving a hydrogen-generating effervescent tablet (releasing ~4 mg H2) in ~250 mL of room-temperature water, consumed on an empty stomach. Participants self-administer at home after ins...